Simplifying Your Digital Health Benefits for the Top 5 Most Costly Chronic Conditions
Missed out on Noom's Webinar regarding GLP-1s and 2024 key predictions? BenefitsPRO has you covered! They wrapped up a nice summary on the predictions Linda Anegawa, MD, Dipl. ABOM, DNBPAS and Jordan Galante Hidalgo discussed + the impact it will have on employee benefits. #glp1 #ozempic #wegovy #mounjaro #noom #aom https://lnkd.in/gxXZYmdE
Missed out on Noom's Webinar regarding GLP-1s and 2024 key predictions? BenefitsPRO has you covered! They wrapped up a nice summary on the predictions Linda Anegawa, MD, Dipl. ABOM, DNBPAS and Jordan Galante Hidalgo discussed + the impact it will have on employee benefits. https://lnkd.in/gxXZYmdE
NFP Employee Benefit Advisor with nearly 20 years' of experience. Transforming the industry by challenging traditional brokers with a proven process for confident, clear benefit packages. #BenefitsInnovation
Are the cost of prescriptions driving the utilization of your company’s employee benefits?! Most employers would answer YES! ✅✅ Listen to NFP’s Insights from the Experts to learn how drug importation could save you some 💲💲
For all the employers out there who are still undecided or want to revisit their weight loss drug coverage strategy, the Benefit Leader's Guide to Weight Loss Drug Coverage eBook is for you! Employers have LOTS of options before deciding to absorb the expenses for covering these drugs, and this resource will help you discover alternatives and best practices when making GLP-1 drug coverage decisions. Download today: https://ow.ly/vmI950RILjU
HR Dive covered Marsh McLennan Agency’s recent webinar about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. Panelists discussed the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary. #EmployerBenefits #WeightLoss #RX #MarshMMA
🌟 Navigating Careers: Where Talent Meets Opportunity 🚀 Guiding Journeys of Excellence 🎙️ Podcast Producer
HR Dive covered Marsh McLennan Agency’s recent webinar about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. Panelists discussed the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary. #EmployerBenefits #WeightLoss #RX #MarshMMA
Employee Health & Benefits Consultant | Business Insurance Broker at Marsh McLennan Agency - Bouchard
HR Dive covered Marsh McLennan Agency’s recent webinar about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. Panelists discussed the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary. #EmployerBenefits #WeightLoss #RX #MarshMMA
HR Dive covered Marsh McLennan Agency’s recent webinar about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. Panelists discussed the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary. #EmployerBenefits #WeightLoss #RX #MarshMMA
HR Dive covered Marsh McLennan Agency’s recent webinar about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. Panelists discussed the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary. #EmployerBenefits #WeightLoss #RX #MarshMMA
HR Dive covered Marsh McLennan Agency’s recent webinar about the decisions employers must make with the introduction of drugs like Ozempic and Wegovy. Panelists discussed the pros and cons of GLP-1s from an employer’s perspective and best practices for adding them to your formulary. #EmployerBenefits #WeightLoss #RX #MarshMMA
